Characterization of Innate Binding Specificities of Peptidoglycan Binding Protein
肽聚糖结合蛋白的固有结合特异性的表征
基本信息
- 批准号:8882250
- 负责人:
- 金额:$ 21.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesApplications GrantsAutoimmune DiseasesBacillus cereusBacteriaBacterial InfectionsBasic ScienceBindingBinding ProteinsBinding SitesBiological AssayBlood PlateletsBuffersCell WallCellsChemistryCleaved cellClinical ResearchColorComplementary DNADensitometryDetectionDiagnosisDiseaseDrosophila pros proteinEmployee StrikesEnterococcus faecalisEnzymesEscherichia coliExcisionGoalsGram-Negative BacteriaGram-Positive BacteriaHIVHealthHemocytesHemolymphHigh Pressure Liquid ChromatographyHumanImmune systemInflammationInsectaKlebsiella pneumonia bacteriumLarvaLengthLepidopteraLysostaphinMalignant NeoplasmsManducaManduca sextaMeasuresMembraneMembrane ProteinsMeningitisMethodsMicrobeMonophenol MonooxygenaseMuramic AcidMuramidaseMutateNatural ImmunityNosocomial InfectionsOklahomaOryctolagus cuniculusPathogen detectionPeptidoglycanPerformancePolyacrylamide Gel ElectrophoresisPolysaccharidesPrecipitationProtein BindingProteinsQuality ControlReactionRecombinant ProteinsRecombinantsResearchRiskRoleSamplingSepsisSeptic ShockSerine ProteaseSourceSpecificityStaphylococcus aureusSupplementationSurfaceTechnologyTestingThickTransfusionUniversitiesVertebral columnbaseblood productcomplement systemcrosslinkimprovedinnovationmicrobialmutanolysinpathogenpeptidoglycan recognition proteinpolyclonal antibodypro-phenoloxidaseprotein expressionresearch studyscreeningsystems research
项目摘要
DESCRIPTION (provided by applicant): BacTx(R) technology, developed by Immunetics for detection of bacteria, employs a unique and innovative assay chemistry to detect Gram-positive and Gram-negative bacteria. The technology is based on components of the innate immune system of the tobacco hornworm (Manduca sexta), in particular the prophenoloxidase cascade, in which serine proteases cleave prophenoloxidase to phenoloxidase, which subsequently oxidizes chromogen to generate a colored reaction product. The BacTx(R) Bacterial Detection Kit received 510(k) clearance from the FDA (CBER) in June 2012 as a quality control test for bacterial contamination in platelets. For M. sexta and other Lepidoptera, the most potent elicitor of the prophenoloxidase cascade is peptidoglycan, which is a major structural component of bacterial cell walls. In this application we propose to biochemically characterize the relationship
between the presence of specific bacterial cell wall features and evasion of detection by pathogen recognition proteins present in M. sexta hemolymph. The role of these features in inhibiting prophenoloxidase activation will be investigated, with the long term goal of potentially
enhancing assay performance and opening up new applications of BacTx(R) technology, including potential use for diagnosis of sepsis, meningitis, and nosocomial infections. Due to the striking similarities between the insect innate immune system and human complement system, this research may also prove significant to elucidating the relationship between inflammation due to bacterial infection and debilitating disorders such as cancer, autoimmune diseases, and septic shock.
描述(由申请人提供):由免疫学用于检测细菌的BACTX(R)技术采用独特而创新的测定化学方法来检测革兰氏阴性和革兰氏阴性细菌。该技术基于烟草虫(Manduca sexta)的先天免疫系统的组成部分,尤其是预防性氧化酶级联反应,其中丝氨酸蛋白酶将预防性氧化酶裂解至苯酚氧化酶,随后将其氧化为氧化以产生彩色反应产物。 BACTX(R)细菌检测试剂盒在2012年6月从FDA(CBER)获得了510(k)的清除,作为血小板细菌污染的质量控制测试。对于M. sexta和其他鳞翅目而言,预测酶级联反应的最有效的引起者是肽聚糖,它是细菌细胞壁的主要结构成分。在此应用中,我们建议以生化为特征
在特定细菌细胞壁特征的存在与sexta Hylymph中存在的病原体识别蛋白逃避检测之间。这些特征在抑制预防氧化酶激活中的作用将被研究,其长期目标是潜在的
提高测定性能并开放BACTX(R)技术的新应用,包括潜在用来诊断败血症,脑膜炎和医院感染。由于昆虫先天免疫系统与人类补体系统之间的惊人相似之处,这项研究也可能对阐明由于细菌感染和使人衰弱的疾病(如癌症,自身免疫性疾病和败血性休克)引起的炎症之间的关系显着。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew E. Levin其他文献
Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
对莱姆病序贯酶免疫分析测试算法的评估表明缺乏测试独立性,但诊断特异性较高。
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:2.9
- 作者:
G. Wormser;Claudia R. Molins;Andrew E. Levin;Susan C. Lipsett;L. Nigrovic;M. Schriefer;J. Branda - 通讯作者:
J. Branda
The Babesia observational antibody (BAOBAB) study: A cross-sectional evaluation of Babesia in two communities in Kilosa district, Tanzania
巴贝虫观察性抗体 (BAOBAB) 研究:坦桑尼亚基洛萨区两个社区巴贝虫横断面评估
- DOI:
10.1371/journal.pntd.0007632 - 发表时间:
2019 - 期刊:
- 影响因子:3.8
- 作者:
E. Bloch;Z. Mrango;M. Kasubi;Jerusha Weaver;Aleksandra Mihailovic;B. Munoz;A. Weimer;Andrew E. Levin;L. Tonnetti;J. Linnen;V. Brès;D. Norris;G. Carpi;S. West - 通讯作者:
S. West
Frequency and magnitude of seroreactivity to <em>Babesia microti</em> in 245 patients diagnosed by PCR in New York State
- DOI:
10.1016/j.diagmicrobio.2020.115008 - 发表时间:
2020-05-01 - 期刊:
- 影响因子:
- 作者:
Susan Madison-Antenucci;Gary P. Wormser;Andrew E. Levin;Susan J. Wong - 通讯作者:
Susan J. Wong
Andrew E. Levin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew E. Levin', 18)}}的其他基金
Point-of-care diagnostic test for T. cruzi (Chagas) infection
克氏锥虫(恰加斯)感染的即时诊断测试
- 批准号:
10603665 - 财政年份:2023
- 资助金额:
$ 21.13万 - 项目类别:
Development of an ELISA for serosurveillance of human hookworm
开发用于人类钩虫血清监测的 ELISA
- 批准号:
10697222 - 财政年份:2023
- 资助金额:
$ 21.13万 - 项目类别:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
用于诊断癫痫患者神经囊尾蚴病的快速护理点检测
- 批准号:
9909230 - 财政年份:2020
- 资助金额:
$ 21.13万 - 项目类别:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
用于诊断癫痫患者神经囊尾蚴病的快速护理点检测
- 批准号:
10084274 - 财政年份:2020
- 资助金额:
$ 21.13万 - 项目类别:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
用于诊断癫痫患者神经囊尾蚴病的快速护理点检测
- 批准号:
10699435 - 财政年份:2020
- 资助金额:
$ 21.13万 - 项目类别:
Hybrid ELISA: Simple and specific one-tier assay for Lyme disease
混合 ELISA:针对莱姆病的简单而特异的一层检测
- 批准号:
9886194 - 财政年份:2019
- 资助金额:
$ 21.13万 - 项目类别:
Biomarker-Based Test of Cure for Chagas Disease
基于生物标记的恰加斯病治愈测试
- 批准号:
10761244 - 财政年份:2019
- 资助金额:
$ 21.13万 - 项目类别:
Hybrid ELISA: Simple and specific one-tier assay for Lyme disease
混合 ELISA:针对莱姆病的简单而特异的一层检测
- 批准号:
10758919 - 财政年份:2019
- 资助金额:
$ 21.13万 - 项目类别:
Biomarker-Based Test of Cure for Chagas Disease
基于生物标记的恰加斯病治愈测试
- 批准号:
9978716 - 财政年份:2019
- 资助金额:
$ 21.13万 - 项目类别:
Point-of-care diagnostic test for T. cruzi (Chagas) infection
克氏锥虫(恰加斯)感染的即时诊断测试
- 批准号:
9757680 - 财政年份:2018
- 资助金额:
$ 21.13万 - 项目类别:
相似海外基金
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
- 批准号:
10667764 - 财政年份:2023
- 资助金额:
$ 21.13万 - 项目类别:
Novel approaches for the treatment of autoimmune disease
治疗自身免疫性疾病的新方法
- 批准号:
10601899 - 财政年份:2023
- 资助金额:
$ 21.13万 - 项目类别:
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
- 批准号:
10481071 - 财政年份:2022
- 资助金额:
$ 21.13万 - 项目类别:
Diabetes Timing and Types and the Effect on Beta Cell Function Post-Acute Pancreatitis in Children
儿童急性胰腺炎后糖尿病发生的时间和类型以及对 β 细胞功能的影响
- 批准号:
10554350 - 财政年份:2022
- 资助金额:
$ 21.13万 - 项目类别: